Event Type
Disclosure
Mandatory
Variant
8-K
and in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 193
Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release of Sionna Therapeutics, Inc. dated March 2, 2026. 104 Cover Page Interactive Data File (embed